The next forum for unraveling FDA off-label marketing rules: State and federal legislatures

Sinha, Michael S.Kesselheim, Aaron2018-06-272018Sinha, Michael S., and Aaron S. Kesselheim. 2018. “The next forum for unraveling FDA off-label marketing rules: State and federal legislatures.” PLoS Medicine 15 (5): e1002564. doi:10.1371/journal.pmed.1002564. http://dx.doi.org/10.1371/journal.pmed.1002564.http://nrs.harvard.edu/urn-3:HUL.InstRepos:37160339In a Guest Editorial, Aaron S. Kesselheim and Michael S. Sinha show how federal and state legislation to allow promotion of drugs for non-approved uses threatens to undermine the FDA's public health mission.en-USPeople and PlacesPopulation GroupingsProfessionsMedical PersonnelMedical DoctorsPhysiciansMedicine and Health SciencesHealth CareHealth Care ProvidersSocial SciencesSociologyMarketingLaw and Legal SciencesLegislationPublic and Occupational HealthLinguisticsSpeechPharmacologyDrug Research and DevelopmentDrug MarketingPeer ReviewThe next forum for unraveling FDA off-label marketing rules: State and federal legislaturesOther2018-06-2710.1371/journal.pmed.1002564